Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma

Author： Escudier Bernard   Albiges Laurence  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.9, 2011-06, pp. : 1179-1191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

By Kaymakcalan Marina D.   Xie Wanling   Albiges Laurence   North Scott A.   Kollmannsberger Christian K.   Smoragiewicz Martin   Kroeger Nils   Wells J. Connor   Rha Sun-Young   Lee Jae Lyun   McKay Rana R.   Fay André P.   De Velasco Guillermo   Heng Daniel Y. C.   Choueiri Toni K.  

Cancer, Vol. 122, Iss. 3, 2016-02 ,pp. : 411-419

Blackwell Publishing

Access to resources Recommend Favorite

Targeted therapy in renal cell carcinoma

By Favaro Justin P   George Daniel J  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1251-1258

Informa Healthcare

Access to resources Recommend Favorite

Targeted-Therapy in Advanced Renal Cell Carcinoma

By  

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1651-1657

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting vascular endothelial growth factor in angina therapy

By Boodhwani Munir   Ramlawi Basel   Laham Roger J   Sellke Frank W  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 5-14

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies in the Treatment of Renal Cell Carcinoma

By  

Current Medicinal Chemistry, Vol. 15, Iss. 12, 2008-05 ,pp. : 1166-1174

Bentham Science Publishers

Access to resources Recommend Favorite